Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

Findings Demonstrate Potential for Amylin and GLP-1 Combinations as Next Generation of Weight Loss and Diabetes Treatment NEW ORLEANS, June 7, 2026 /PRNewswire/ — New international study findings demonstrated positive results of the first injectable glucagon-like peptide-1 receptor…